炎症标记物及其与阿尔茨海默病和轻度认知障碍中的认知功能关系. 系统性审查和元分析
Maria Fernanda Serna1,2, Mildrey Mosquera1, Herney Andrés García-Perdomo3
1Grupo de Nutrición, Department of Physiological Sciences, University of Valle, Cali, Colombia.
Neuromolecular medicine
|July 25, 2025
概括
这项研究发现,在患有阿尔茨海默病 (AD) 和轻度认知障碍 (MCI) 的个体中,某些炎症标志物的血液水平发生了显著变化. 升高的IL-1β,IL-6,MCP-1和TNF-α,以及降低的IL-8和IL-10,表明AD中的强烈炎症反应.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 阿尔茨海默病 (AD) 和轻度认知障碍 (MCI) 与神经炎症有关.
- 了解外周炎症标志物在AD/MCI中的作用对于诊断和治疗至关重要.
研究的目的:
- 系统地审查和元分析血液炎症标志物和AD或MCI的成年人的认知功能之间的关联.
- 在AD/MCI患者中确定特定的炎症标志物,其度发生变化.
主要方法:
- 84项研究的系统审查和元分析 (元分析中75项).
- 在Medline,科学网,SCOPUS,LILACS和CENTRAL数据库中进行了搜索.
- 包括检查血液炎症标志物和AD/MCI认知功能的研究.
主要成果:
- 在AD患者中,IL-1β,IL-6,MCP-1和TNF-α的血液度显著增加.
- 在AD患者中显著降低IL-8和IL-10的血液度.
- 这些变化表明与AD和MCI相关的显著炎症反应.
结论:
- 在患有AD和MCI的个体中,血液炎症标志物概况发生显著变化.
- 升高的IL-1β,IL-6,MCP-1,TNF-α和降低的IL-8,IL-10水平与AD有关.
- 这些发现突显了炎症标志物作为AD和MCI的生物标志物的潜力.
相关概念视频
Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
208
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
208
Role of Neurotransmitters in Memory
992
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
992
Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262
Dementia
166
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
166


